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BMI (P < 0.001), dyslipidaemia (P < 0.001), smoking
(P = 0.017), family history (P = 0.994) and hypertension
with P < 0.001.
Conclusion: The most important predictors of CAD in our
population were age, gender, BMI, dyslipidaemia, dia-
betes mellitus and smoking. Whereas, family history
was not recognized as predictor, this is may be due impro-
per documentation of this variable in patient records.
http://dx.doi:10.1016/j.jsha.2015.05.185
5. Newly developed atrial fibrillation in liver
transplant patient with intravenous dexmedeto-
medine sedation
Adel Hammodi Ali, Ali Al-Azim
Introduction: Atrial fibrillation (AF) is the commonest type
of arrhythmias in common population and critically ill as
well. Intensive care patients are vulnerable to develop AF
due to numerous causing and risk factors during their ill-
ness. Drug-induced AF is a group of underestimated
causes known to induce arrhythmias in severely ill
patients one of these medications is. Dexmetedomedine
(precedx) one of relatively new sedative-analgesic is effec-
tively used in mechanically ventilated patients and as a
consequence recent critical care society recommendations
claimed dexmedetomidine may be preferred over seda-
tion with benzodiazepines.
Case report: We present a case report of newly devel-
oped resistant AF in post living-related liver transplant
lady who received intravenous dexmedetomidine as
recommended sedative to liberate her from the
ventilator.
Discussion: Despite the presence of other clinical risk
factors pertinent to the patient to develop AF which
took place after starting dexmedetomidine, yet the res-
olution of AF had occurred subsequent to cessation of
dexmedetomidine. Retrospective analysis of critical care
department database of king Fahad specialist hospital
Dammam from January 2011 till July 2014 up to
revealed about 20% of patients received intravenous
dexmedetomidine had experienced AF. In fact these
results are higher than the reported information by
the literature.
Conclusion: Intravenous dexmedetomidine (precedex) is
a common cause of AF in critically ill patients. This kind
of side effect needs scrutinized assessment and follow up
to find out the risk factors involved in its development
especially in the era of increasing dexmedetomidine as
a state-of-art recommended sedative agent in intensive
care units and perioperative as well.
http://dx.doi:10.1016/j.jsha.2015.05.186
6. Endovascular treatment for acute traumatic
transection of the thoracic aorta: The safety of
delayed stenting
Adil H. Al Kindi, Rashid Al Sukaiti, Khalifa Al
Wahibi
Objective: The current recommendation is immediate
surgical treatment of acute traumatic transection (ATT)
of the aorta. Open surgical repair carries high morbidity
and mortality. Endovascular repair (TEVAR) has
emerged as a safer option. The timing of intervention
remains a matter of debate We review our outcomes of
delayed endovascular repair of ATT.
Methods: From 2011 to 2013, 7 patients underwent
delayed TEVAR for ATT. All patients had their records
reviewed retrospectively regarding mechanism of injury,
concomitant injuries, technical details, post-operative
complications and long term follow up.
Results: The mean age was 30.29 years (range 24–
51 years) and 6 out of 7 patients were male. The mecha-
nism of injury was motor vehicle collision in 6 patients.
The median time from injury to TEVAR was 8.7 days
and there was no mortality during this period.
Technical success was 100%. None of the patients suf-
fered any neurological events, arrhythmias, acute renal
injury, distal ischemia or endoleak. The median hospital
stay was 10 days and all patients were discharged home
with no hospital mortality. Mean follow up was
12 months and all patients were alive at follow up and
none required re-intervention.
Conclusion: The delayed approach has been safe with no
patients lost during the waiting period. Patients with ATT
who make it to the hospital and are stable from the
aortic point of view may be managed safely with
delayed TEVAR if immediate therapy is not available or
possible.
http://dx.doi:10.1016/j.jsha.2015.05.187
7. Septal myectomy for hypertrophic obstructive
cardiomyopathy in the young adults and children
Salah Eldien Altarabsheh, Salil Deo, Joseph
Dearani, Hartzell Schaff
Purpose: Hypertrophic obstructive cardiomyopathy
(HOCM) is one of the leading causes for heart failure in
the young; few studies were published the results of sur-
gical therapy in this age category. Our aim was to assess
the late results of basal septal myectomy in the young.
Methods: We retrospectively reviewed the records of 128
consecutive patients (38% female), age less than 21 years,
who underwent basal septal myectomy for HOCM in the
period between 1975 and 2010 at the Mayo Clinic
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